Main research fields:

  • Exploration of new prognostic biomarkers of cancer. It involves the investigation of the impact of genetic factors on the pathogenesis of solid tumours and their prognostic value
  • Investigating the molecular mechanisms of myeloproliferative diseases in cell cultures. Analysis of cell signalling pathways involved in the aetiopathogenesis of oncohematological diseases
  • Investigation of the effects of drugs in cell culture models. Exploration of the molecular mechanisms of anticancer effects of different drugs, potentially leading to personalised treatment and more effective drug combinations
  • Radiobiological research. Analysis of the response of breast cancer cells to ionising radiation and the molecular mechanisms of this response